Mobile-Menu

MENA: Pharma Middle East and Africa’s Pharma Economy to Achieve 38.8 Billion Dollars by 2021

Editor: Ahlam Rais

Based on last year’s sales, Saudi Arabia remains the biggest pharma market in the region followed by Turkey, Egypt and the UAE. Across the MENA region, the total pharma sales have reached 32 billion dollars.

Related Companies

De Facto Communications
Pörner Ingenieurgesellschaft mbH
TRM Filter d.o.o.
Frewitt fabrique de machines SA
The increasing populations in Sub-Saharan African countries and the development of healthcare systems in the Middle East are providing robust growth opportunities for the pharma sector.
The increasing populations in Sub-Saharan African countries and the development of healthcare systems in the Middle East are providing robust growth opportunities for the pharma sector.
(Source: Deposit Photos)

Amsterdam/The Netherlands – Favourable market conditions are driving increased growth across the Middle East and North Africa (MENA) pharma market – ageing and gentrifying populations, increased healthcare spending, and a modernising supply chain are transforming prospects in the region, according to Cphi Mea.

Total pharma sales have reached an impressive 32 billion dollars across MENA as a whole – the Middle East accounts for 20.3 billion dollars and North Africa 10.7 billion dollars. The increasingly gentrified populations in Sub-Saharan African countries and the development of sophisticated universal healthcare systems in the Middle East are providing robust growth opportunities.

In particular, the finished dosage formulation sector is expanding particularly quickly in the Middle East, with a number of plants being commissioned in the last few years. In the UAE, the government also fast-tracks approval of locally manufactured drugs, which is helping to establish a new manufacturing base in the country – with the added potential for exports to the Gulf Cooperation Council.

Cara Turner, Brand Director – CphI Middle East & Africa, UBM, added, “Many companies are receiving a direct boost from government policy changes and are building new manufacturing facilities in the region, which is seeing the sector perform strongly. Domestic production accounts for approximately 45 % of drug consumption in the Middle East, with generics in the GCC alone valued at 1.55 billion dollars in 2016.”

Saudi Arabia remains the biggest pharma market in the region according to 2017 sales numbers at 7.5 billion dollars, with Turkey (6.9 billion dollars), Egypt (3.4 billion dollars) and the UAE (3.17 billion dollars) following closely behind. However, overall the North Africa region is predicted to see the fastest growth rates in the next few years at 7.6 % CAGR.

Subscribe to the newsletter now

Don't Miss out on Our Best Content

By clicking on „Subscribe to Newsletter“ I agree to the processing and use of my data according to the consent form (please expand for details) and accept the Terms of Use. For more information, please see our Privacy Policy.

Unfold for details of your consent

(ID:45450155)

Related content